Coeptis Therapeutics to Acquire Z Squared in Merger Agreement
ByAinvest
Saturday, Apr 26, 2025 2:47 pm ET1min read
COEP--
Coeptis Therapeutics (NASDAQ:COEP) has entered into a merger agreement with Z Squared, resulting in Z Squared becoming a wholly-owned subsidiary of Coeptis. Under the terms of the agreement, a subsidiary of Coeptis will merge with Z Squared, with the deal expected to close in Q4 2023. The merger is subject to customary closing conditions, including regulatory approvals.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet